NCT06444711View on ClinicalTrials.gov

OPTIMISation of Cardio-renal-metabolic-pulmonary Disease Guideline Adherence in High Risk Community Dwelling Individuals

NAActive, not recruitingINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

May 7, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

April 30, 2045

Conditions
Cardiovascular DiseasesRenal DiseaseMetabolic DiseasePulmonary Disease
Interventions
OTHER

NICE guidance

Patients will be assessed to determine whether their current treatment is in line with NICE guidelines. Changes will be made to their treatment plan in order for them to comply with NICE guidelines with the aim of reducing the number of serious adverse events in the group. They will be followed up until 6 months to identify improvements in their conditions

Trial Locations (1)

LS2 9JT

University of Leeds, Leeds

All Listed Sponsors
lead

University of Leeds

OTHER